The first tubeless automated insulin delivery system — a wearable pod with the SmartAdjust algorithm built right into the pod itself. No tubing, pharmacy access, and control from a compatible phone or the provided Controller.
Device specifications change frequently — always verify current information directly with the manufacturer before making any decisions. Full disclaimer.
New to Omnipod 5? Start here.
Disclosure: Omnipod (Insulet) is a current Juicebox Podcast sponsor, and omnipod.com/juicebox is a sponsor link. This guide is educational and is not a recommendation to choose one system over another. The Omnipod 5 is the automated (AID) system; for the manual, non-automated pod pump, see the Omnipod Dash profile.
Omnipod 5 is an automated insulin delivery (AID) system built into a tubeless, wearable pod. The SmartAdjust algorithm lives inside the pod itself — not in a separate controller — and adjusts insulin every 5 minutes based on CGM data and a customizable glucose target. There's no tubing, the system is available through the pharmacy benefit, and it can be controlled from a compatible smartphone or the provided Omnipod 5 Controller. It integrates with Dexcom and FreeStyle Libre sensors, and is cleared for both type 1 and type 2 diabetes.
Uniquely, the SmartAdjust algorithm runs inside the pod itself — not in the phone or controller. This means automation continues even if your phone is out of range, since the pod makes its own dosing decisions.
Omnipod 5 can be controlled from a compatible smartphone app — bolusing directly from your phone — or from the provided Omnipod 5 Controller. This is a key convenience many patients value.
Like Omnipod Dash, Omnipod 5 is available through the pharmacy benefit — filled like a prescription rather than going through DME suppliers. This is a meaningful access difference for many patients.
Omnipod 5 integrates with Dexcom G6 and G7, and with FreeStyle Libre 2 Plus — giving patients CGM flexibility within a tubeless AID system. Confirm current cleared pairings for your region.
Putting the algorithm inside the pod is the defining Omnipod 5 idea: automation keeps running on the body even when the phone isn't nearby, and the whole system stays tubeless and pharmacy-accessible.
— Juicebox Podcast Omnipod 5 GuideSmartAdjust algorithm runs in the pod, adjusting insulin every 5 minutes toward a customizable target (110–150 mg/dL). Automation continues without the phone in range. No tubing.
Pharmacy benefit — filled like a prescription. Cleared for type 1 and type 2 diabetes. Phone or Controller operation. Confirm current age indications and coverage.
Dexcom G6/G7 and FreeStyle Libre 2 Plus. Confirm current cleared pairings and app/phone compatibility for the patient's device and region.
Customizable glucose targets (110–150 mg/dL) plus standard programmable settings. Activity feature for exercise. Good settings still drive outcomes as with any AID system.
Omnipod 5's tubeless design and in-pod algorithm shape how it's used day to day. Here's how SmartAdjust works, how to think about targets and the Activity feature, and what still requires user action.
SmartAdjust uses CGM values and trend to predict glucose 60 minutes ahead, adjusting basal insulin delivery every 5 minutes toward your target. It increases, decreases, or pauses insulin to head off highs and lows — all from the algorithm running in the pod.
You can set glucose targets from 110 to 150 mg/dL in 10 mg/dL increments — and set different targets for different times of day. This flexibility lets you tune how aggressive the automation is for your needs.
The Activity feature reduces insulin delivery for a set period to lower hypoglycemia risk during and after exercise — Omnipod 5's version of an exercise mode. Turn it on around activity and off afterward.
The pod is worn directly on the body with no tubing and is waterproof within Insulet's stated spec — supporting swimming and showering. Each pod lasts up to 3 days, then is replaced.
The customizable target (110–150 mg/dL) is the primary automation lever. Patients not meeting goals may be running a higher target than appropriate; those with hypoglycemia concerns may benefit from a higher target or Activity use. Schedule targets by time of day where useful.
SmartAdjust manages basal, but meal boluses remain the patient's job. Reinforce accurate carb counting and pre-bolusing for post-prandial control. The algorithm supplements but doesn't replace good bolusing habits.
Counsel on using Activity before and during exercise to reduce lows. Non-use is a common reason for exercise-related hypoglycemia on AID. Set expectations for turning it on ahead of activity.
3-day pod wear; reinforce site rotation to avoid lipohypertrophy and absorption issues. As a pod system, site problems are a common cause of unexplained highs. Confirm CGM setup and data sharing for reviews.
Omnipod 5 has a distinctive architecture (algorithm in the pod), a growing evidence base across type 1 and type 2 diabetes, and the practical advantages of a tubeless, pharmacy-accessible system. Here's the fuller picture for clinicians and power users.
Algorithm runs in the pod. ~60-min prediction horizon; basal adjustment every 5 minutes toward a customizable target (110–150 mg/dL). Automation continues without phone/controller in range.
Tubeless pod, ~3-day wear, waterproof within spec. Pharmacy benefit (not DME). Phone or Controller operation. Cleared for T1D and T2D.
Dexcom G6/G7 and FreeStyle Libre 2 Plus. Compatible-phone and cleared-pairing lists change over time — confirm current specifics per region.
Customizable targets by time of day. Activity feature reduces delivery for exercise. Standard bolus workflow (carb entry, pre-bolus) still applies.
Published T1D pivotal/real-world data (pediatric & adult) showing TIR/A1c benefits; studied and cleared for T2D. Interpret alongside independent literature; outcomes are settings-dependent.
Meal announcement/bolus, ~3-day pod changes, CGM sensor changes, Activity use for exercise, site rotation. SmartAdjust reduces basal burden but does not remove these.